Literature DB >> 10479465

Health benefits of docosahexaenoic acid (DHA)

L A Horrocks1, Y K Yeo.   

Abstract

Docosahexaenoic acid (DHA) is essential for the growth and functional development of the brain in infants. DHA is also required for maintenance of normal brain function in adults. The inclusion of plentiful DHA in the diet improves learning ability, whereas deficiencies of DHA are associated with deficits in learning. DHA is taken up by the brain in preference to other fatty acids. The turnover of DHA in the brain is very fast, more so than is generally realized. The visual acuity of healthy, full-term, formula-fed infants is increased when their formula includes DHA. During the last 50 years, many infants have been fed formula diets lacking DHA and other omega-3 fatty acids. DHA deficiencies are associated with foetal alcohol syndrome, attention deficit hyperactivity disorder, cystic fibrosis, phenylketonuria, unipolar depression, aggressive hostility, and adrenoleukodystrophy. Decreases in DHA in the brain are associated with cognitive decline during aging and with onset of sporadic Alzheimer disease. The leading cause of death in western nations is cardiovascular disease. Epidemiological studies have shown a strong correlation between fish consumption and reduction in sudden death from myocardial infarction. The reduction is approximately 50% with 200 mg day(-1)of DHA from fish. DHA is the active component in fish. Not only does fish oil reduce triglycerides in the blood and decrease thrombosis, but it also prevents cardiac arrhythmias. The association of DHA deficiency with depression is the reason for the robust positive correlation between depression and myocardial infarction. Patients with cardiovascular disease or Type II diabetes are often advised to adopt a low-fat diet with a high proportion of carbohydrate. A study with women shows that this type of diet increases plasma triglycerides and the severity of Type II diabetes and coronary heart disease. DHA is present in fatty fish (salmon, tuna, mackerel) and mother's milk. DHA is present at low levels in meat and eggs, but is not usually present in infant formulas. EPA, another long-chain n-3 fatty acid, is also present in fatty fish. The shorter chain n-3 fatty acid, alpha-linolenic acid, is not converted very well to DHA in man. These longchain n-3 fatty acids (also known as omega-3 fatty acids) are now becoming available in some foods, especially infant formula and eggs in Europe and Japan. Fish oil decreases the proliferation of tumour cells, whereas arachidonic acid, a longchain n-6 fatty acid, increases their proliferation. These opposite effects are also seen with inflammation, particularly with rheumatoid arthritis, and with asthma. DHA has a positive effect on diseases such as hypertension, arthritis, atherosclerosis, depression, adult-onset diabetes mellitus, myocardial infarction, thrombosis, and some cancers. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479465     DOI: 10.1006/phrs.1999.0495

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  130 in total

Review 1.  Nutrition implications for fetal alcohol spectrum disorder.

Authors:  Jennifer K Young; Heather E Giesbrecht; Michael N Eskin; Michel Aliani; Miyoung Suh
Journal:  Adv Nutr       Date:  2014-11-14       Impact factor: 8.701

Review 2.  Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop.

Authors:  Kohji Fukunaga; Norifumi Shioda
Journal:  Mol Neurobiol       Date:  2011-12-20       Impact factor: 5.590

3.  The fatty acid oxidation product 15-A3t-isoprostane is a potent inhibitor of NFκB transcription and macrophage transformation.

Authors:  Joshua D Brooks; Erik S Musiek; Tyler R Koestner; Jeannette N Stankowski; Jocelyn R Howard; Enrico M Brunoldi; Alessio Porta; Giuseppe Zanoni; Giovanni Vidari; Jason D Morrow; Ginger L Milne; BethAnn McLaughlin
Journal:  J Neurochem       Date:  2011-09-23       Impact factor: 5.372

4.  Proteolytic extraction of salmon oil and PUFA concentration by lipases.

Authors:  Michel Linder; Jacques Fanni; Michel Parmentier
Journal:  Mar Biotechnol (NY)       Date:  2005-02-17       Impact factor: 3.619

Review 5.  Production of eicosapentaenoic and docosahexaenoic acid-containing oils in transgenic land plants for human and aquaculture nutrition.

Authors:  Stanley S Robert
Journal:  Mar Biotechnol (NY)       Date:  2006-01-01       Impact factor: 3.619

6.  Ramelteon Improves Post-traumatic Stress Disorder-Like Behaviors Exhibited by Fatty Acid-Binding Protein 3 Null Mice.

Authors:  Yasushi Yabuki; Ibuki Takahata; Kazuya Matsuo; Yuji Owada; Kohji Fukunaga
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

7.  Fatty acid profiles of muscle from large yellow croaker (Pseudosciaena crocea R.) of different age.

Authors:  Hong-gang Tang; Li-hong Chen; Chao-geng Xiao; Tian-xing Wu
Journal:  J Zhejiang Univ Sci B       Date:  2009-02       Impact factor: 3.066

8.  The high-level accumulation of n-3 polyunsaturated fatty acids in transgenic pigs harboring the n-3 fatty acid desaturase gene from Caenorhabditis briggsae.

Authors:  Yanrong Zhou; Yanli Lin; Xiaojie Wu; Chong Feng; Chuan Long; Fuyin Xiong; Ning Wang; Dengke Pan; Hongxing Chen
Journal:  Transgenic Res       Date:  2013-09-19       Impact factor: 2.788

9.  Production of Lipids and Proteome Variation in a Chilean Thraustochytrium striatum Strain Cultured under Different Growth Conditions.

Authors:  Carolina Shene; Marcelo Garcés; Daniela Vergara; Jhonatan Peña; Stéphane Claverol; Mónica Rubilar; Allison Leyton
Journal:  Mar Biotechnol (NY)       Date:  2018-11-19       Impact factor: 3.619

10.  Effect of omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation to lactating sows on growth and indicators of stress in the postweaned pig1,2.

Authors:  John M McAfee; Henry G Kattesh; Merlin D Lindemann; Brynn H Voy; Cheryl J Kojima; Nicole C Burdick Sanchez; Jeff A Carroll; Barbara E Gillespie; Arnold M Saxton
Journal:  J Anim Sci       Date:  2019-11-04       Impact factor: 3.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.